• Issues
    • Current Issue
    • Special Issues
  • Viewpoints
    • Editor’s Corner
    • Advanced Practice Voices
    • From Our Readers
      • You Make the Call: Readers’ Response
      • Guest Commentary
      • Letters to the Editor
    • A Day in the Life
    • Notes From the Hill
    • The Break Room
  • Education
    • You Make the Call
    • Hematologica Obscura
    • How I Teach
    • How I Treat In Brief
    • Demystifying the Lab
    • Practice Update
  • Spotlight
    • Feature Articles
    • Pulling Back the Curtain
    • Blood Beyond Borders
    • pASHions
    • Drawing First Blood
    • Interviews
  • News
    • Online Exclusives
    • Latest & Greatest
    • From the Blood Journals
      • Written in Blood
      • Blood Advances in a Different Vein
    • Literature Scan
    • ASH Directions
    • The Society Pages
  • Topic Compilations
    • COVID-19 News
    • Acute Leukemias
    • Chronic Leukemias
    • MDS & Myeloproliferative Neoplasms
    • Multiple Myeloma & Plasma Cell Disorders
    • Lymphomas & Lymphoid Neoplasia
    • Bleeding Disorders
    • Clotting Disorders
    • Red Blood Cell & Iron Disorders
  • On Location
    • ASH Annual Meeting
    • ASH Meeting on Hematologic Malignancies
    • ASH Meeting on Lymphoma Biology
    • Other Meetings
  • Multimedia
    • Sound Bites
    • Meeting Coverage
Search
  • ASH Home
  • About ASH Clinical News
  • Authors
  • Advertising
  • Subscribe
  • Contact Us
  • eNewsletters
  • Cookie Settings
  • LOG IN
Welcome! Log into your account
Forgot your password?
Recover your password
ASH Clinical News
  • Issues
    • AllCurrent IssueSpecial Issues

      March 2021 Special Edition

      March 2021 Volume 7 Issue 4

      February 2021 Volume 7 Issue 3

      Mid-January 2021 Annual Meeting Edition

  • Viewpoints
    • Editor’s Corner
    • Advanced Practice Voices
    • From Our Readers
      • You Make the Call: Readers’ Response
      • Guest Commentary
      • Letters to the Editor
    • A Day in the Life
    • Notes From the Hill
    • The Break Room
  • Education
    • You Make the Call
    • Hematologica Obscura
    • How I Teach
    • How I Treat In Brief
    • Demystifying the Lab
    • Practice Update
  • Spotlight
    • Feature Articles
    • Pulling Back the Curtain
    • Blood Beyond Borders
    • pASHions
    • Drawing First Blood
    • Interviews
  • News
    • Online Exclusives
    • Latest & Greatest
    • From the Blood Journals
      • Written in Blood
      • Blood Advances in a Different Vein
    • Literature Scan
    • ASH Directions
    • The Society Pages
  • Topic Compilations
    • COVID-19 News
    • Acute Leukemias
    • Chronic Leukemias
    • MDS & Myeloproliferative Neoplasms
    • Multiple Myeloma & Plasma Cell Disorders
    • Lymphomas & Lymphoid Neoplasia
    • Bleeding Disorders
    • Clotting Disorders
    • Red Blood Cell & Iron Disorders
  • On Location
    • ASH Annual Meeting
    • ASH Meeting on Hematologic Malignancies
    • ASH Meeting on Lymphoma Biology
    • Other Meetings
  • Multimedia
    • Sound Bites
    • Meeting Coverage
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
    Christopher Flowers, MD

    Christopher Flowers, MD

    Department Chair, Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
    • 2020 ASH Annual Meeting Preview: Conversations With Co-Chairs Monday, November 16th, 2020

      Education Program Co-chairs

    Sabrina Ahle
    Advertisement

    Current Issue

    March 2021 Volume 7 Issue 4

    Monday, March 1, 2021
    This issue examines the 21st Century Cures Act’s information blocking requirements, blood services around the globe, and more.

    Block title

    Novartis and the Gates Foundation Collaborate on Off-the-Shelf Gene Therapy for Sickle Cell Disease

    Tuesday, March 2, 2021

    ‘All of Us’ Technology Platform Aims to Democratize Research

    Tuesday, March 2, 2021

    FDA Accepts sNDA for Zanubrutinib in Waldenström Macroglobulinemia

    Tuesday, March 2, 2021

    Crizotinib Approved for Relapsed/Refractory Systemic ALCL

    Monday, March 1, 2021

    Daratumumab and Hyaluronidase-fihj Approved for Light Chain Amyloidosis

    Monday, March 1, 2021
    Recent Posts
    • Novartis and the Gates Foundation Collaborate on Off-the-Shelf Gene Therapy for Sickle Cell Disease
    • ‘All of Us’ Technology Platform Aims to Democratize Research
    • FDA Accepts sNDA for Zanubrutinib in Waldenström Macroglobulinemia
    • Crizotinib Approved for Relapsed/Refractory Systemic ALCL

    Meeting Coverage

    Researchers Validate Burkitt Lymphoma Prognostic Index

    Monday, March 1, 2021

    Thiotepa-Containing Conditioning Regimens Improve Survival Outcomes in Patients With PCNSL

    Monday, March 1, 2021

    Editor's Corner

    Editor’s Corner: Healing Our Invisible Wounds

    Monday, March 1, 2021

    Editor’s Corner: A Period Piece

    Monday, February 1, 2021
    2021 L Street NW, Suite 900, Washington, DC 20036
    Phone 202-776-0544 | Fax 202-776-0545
    • ASH Home
    • Research
    • Education
    • Advocacy
    • Meetings
    • Publications
    • ASH Store
    Copyright © 2020 by American Society of Hematology

    Contact Us | Terms of Service | Privacy Policy